DIMETHYL FUMARATE
| Brand name | TECFIDERA |
|---|---|
| Active ingredient | DIMETHYL FUMARATE |
| Strength | 240MG |
| Dosage form | CAPSULE, DELAYED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | March 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11246850 | November 2035 | use U-1384 |
| 10959972 | November 2035 | use U-1384 |
| 11129806 | November 2035 | use U-1384 |
| 11007167 | November 2035 | use U-1384 |
| 11007166 | November 2035 | use U-1384 |
| 10391160 | March 2035 | use U-3148 |
| 10555993 | March 2035 | use U-3148 |
| 10994003 | March 2035 | use U-3148 |
| 8399514 | February 2028 | use U-1384 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.